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effective programs to curtail the 
spread of TB within the country and 
the region; in this era of globalization, 
it is required for the successful control 
of TB worldwide.
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Hemorrhagic Fever 
with Renal 
Syndrome, Vietnam
To the Editor: Hantaviruses are 
primarily rodent borne and can cause 
hemorrhagic fever with renal syndrome 
(HFRS) in persons who inhale aero-
solized excreta from infected rodents. 
The clinical characteristics of HFRS 
are fever, hemorrhage, and varying de-
grees of renal and hepatic dysfunction. 
Although HFRS is endemic primarily 
to Eurasian regions, there is serologic 
evidence of hantavirus infections in 
rodents and humans worldwide (1). 
Little is known about the occurrence 
of hantavirus infection in rodents or 
humans in Vietnam. One study found 
5.4% prevalence of antibodies against 
Hantaan 76–118 and Puumala strains 
among residents of the Hanoi Metro-
politan (2), whereas another study in 
southern Vietnam did not ﬁ  nd evidence 
of hantavirus infection in humans (3). 
We describe autochthonous HFRS 
from Vietnam, possible reservoir hosts, 
and the follow-up investigation, which 
implies the presence of a strain of Seoul 
virus (SEOV).
The case-patient was a previously 
healthy 25-year-old nurse working in a 
referral hospital and residing in a semi-
urban district of Ho Chi Minh City. On 
September 23, 2008, she was admitted 
to the referral hospital with a history 
of high fever, chills, myalgia, nausea, 
vomiting, hematuria, and abdomi-
nal and lower back pain for 3 days. 
Physical examination showed a body 
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temperature of >39°C, petechiae, mild 
dehydration and hypotension, with 
otherwise unremarkable vital signs. 
Hematologic tests showed 13,300 leu-
kocytes/mm3, 167,000 thrombocytes/
mm3, and hematocrit of 31%. Urinaly-
sis showed grave hematuria (3+), pro-
teinuria (2+), and leukouria (2+).
Three days after admission, acute 
renal failure with relative oliguria (0.85 
L/24 h) developed, as well as uremia 
(26.4 mg/dL), creatinemia (0.98 mg/
dL), and abnormal liver function (as-
partate aminotransferase 49 U/L and 
alanine transferase 60 U/L). The fol-
lowing day the patient had dyspnea 
and became agitated. Ultrasound ex-
amination showed pleural effusion, 
parietal pericardial effusion, peritoneal 
ascites, hepatomegaly, and renal thick-
ness. Six days after admission, diuretic 
problems developed in the patient (3.7 
L/24 h), her dyspnea resolved, and she 
became afebrile. Ten days after admis-
sion, the patient’s hematuria resolved, 
and renal and liver functions gradually 
recovered; she was discharged after 29 
days of hospitalization.
Immunoglobulin (Ig) M and IgG 
against Hantaan recombinant nucleo-
capsid protein antigen were detected 
in the case-patient’s acute-phase and 
convalescent-phase serum samples, 
respectively, by ELISA (4,5). The 
presence of antihantavirus IgG was 
conﬁ  rmed by immunoﬂ  uorescent anti-
body (IFA) assay using whole hanta-
virus antigen and Western blot using 
hantavirus CL-1 strain (6,7). In fur-
ther analysis, neutralization antibodies 
against SEOV strain SR-11 were de-
tected by focus reduction neutraliza-
tion test (8). The viral RNA, however, 
was not detectable in the acute-phase 
blood sample by reverse transcrip-
tion–PCR (RT-PCR) (9). Other sero-
logic tests were performed for dengue 
fever, typhoid fever, hepatitis B, and 
malaria; results of culture of blood and 
urine were negative for bacteria.
Following conﬁ  rmation of the di-
agnosis, close contacts of the patient 
were investigated. Two family mem-
bers of the patient did not have any 
symptoms compatible with HFRS; 
their serum samples were tested and 
found negative for antihantavirus IgG. 
Because the patient was a nurse, pos-
sible nosocomial transmission and 
sources were also investigated and 
excluded. On the basis of the patient’s 
strong history of exposure to rodents 
at home, further investigation focused 
on the domestic rodent population.
From October 14 through 16, 
2008, 110 rodent traps were set within 
and surrounding the patient’s house. 
The total catch was 32 rodents, of 
which 16 were Rattus norvegicus, 7 
R. exulans, 5 R. argentiventer, and 4 
Bandicota indica, respectively. By us-
ing ELISA, IFA, and Western blot, an-
tihantavirus IgG was detected in serum 
from 7 rats, of which 5 were R. nor-
vegicus, 1 R. argentiventer, and 1 B. 
indica. Further analysis using RT-PCR 
identiﬁ  ed 2 SEOV strains from R. nor-
vegicus and R. argentiventer captured 
in the patient’s house. The M segment 
of 1 identiﬁ  ed SEOV strain (24D1208) 
was sequenced and compared with 22 
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Figure. Phylogenetic tree (CLC-Combined Workbench 3) showing partial sequences of the 
medium segment (nt 810–2355). The newly identiﬁ  ed Seoul virus (SEOV) was denoted 
as 24D1208 (arrow). The M segment sequences of the reference strains are: SEOV 
strains KI-88-15 (D17594), KI-85-1 (D17593), KI-83-262 (D17592), SR11 (M34882), 80–
39 (S47716), Jakarta137 (AJ620583), Haiphong port #7 (AB355728), Haiphong port #20 
(AB355730), Haiphong port #16 (AB355729), Hanoi #25 (AB355733), Hanoi #9 (AB355732), 
Haiphong port #28 (AB355731), B-1 (X53861), BjHD01 (DQ133505), ZT71 (EF117248), 
ZT10 (DQ159911), K24-e7 (AF288652), K24-v2 (AF288654), HB55 (AF035832), IR461 
(AF458104), Gou3-e5 (AF288650), and ZJ5 (FJ811839); Thailand virus strain 749 (L08756); 
Hantaan virus strains 76–118 (M14627), Hantaan (NC005219), LEE (D00377) and Hojo 
(D00376); Dobrava virus (DOBV) strain Dobrava (L33685); Puumala virus strain Sotkamo 
(X61034); Tula virus (TUV) strain Tula/Moravia/5302v/95 (Z69993); and Sin Nombre virus 
(SNV) strain NMH10. The numbers at the nodes are bootstrap conﬁ  dence levels for 1,000 
replications. Only bootstrap support values >70% are shown.LETTERS
SEOV strains, 6 of which were from 
R. norvegicus rodents captured in ur-
ban areas of North Vietnam. Phyloge-
netic analysis showed that this SEOV 
belonged to the Vietnamese SEOV 
genotype (Figure).
We describe a clinical case of 
hantavirus infection and its potential 
rodent reservoir occurring in Vietnam. 
The clinical manifestations of the case-
patient were compatible with SEOV in-
fection, which is responsible for a mod-
erate form of HFRS (10). Also, HFRS 
caused by SEOV occurs in urban rather 
than rural areas, unlike other hantavirus 
infections. Our epidemiologic ﬁ  ndings 
were compatible with other studies 
indicating the source of infection was 
the case-patient’s home, the only place 
where she had a history of exposure to 
rodents. Although viral RNA could not 
be obtained from the case-patient for 
genotyping, the genomic comparison of 
the viral strains from rodents captured in 
the case-patient’s home and elsewhere 
in Vietnam suggested that the source of 
infection was local rodents. This report 
provides additional evidence that hanta-
virus infection is a worldwide problem 
and is likely underdiagnosed in Viet-
nam and other countries where simple 
standardized laboratory diagnostics are 
not widely available.  
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Origin of Highly 
Pathogenic Porcine 
Reproductive and 
Respiratory 
Syndrome Virus, 
China
To the Editor: A highly patho-
genic porcine reproductive and respi-
ratory syndrome virus (HP-PRRSV), 
which affected >2 million pigs, 
emerged in early 2006 in the People’s 
Republic of China. The disease was 
characterized by high fever (41°C), 
high illness rates (50%–100%), and 
high death rates (20%–100%) for 
pigs of all ages (1). A number of 
HP-PRRSVs have been isolated from 
2006 through 2009 from infected pigs 
in different provinces of China and 
conﬁ  rmed to be the causative agent 
of the new outbreaks (1,2). These 
HP-PRRSVs have a deletion of 30 
amino acids in nonstructural protein 
2 (NSP-2). However, the evolution-
ary origin and path of the HP-PRRSV 
remain unknown.
We analyzed the full-length 
sequences of 67 PRRSVs: 35 HP-
PRRSVs (HuN4 and LNSY-08-1 iso-
lated in our laboratory and 33 viruses 
isolated in other laboratories), 28 
classic PRRSVs (18 viruses isolated 
from China and 10 viruses represent-
ing other Asian countries and North 
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